China Reform Fund Management
VC Fund
Beijing, China
China Reform Fund Management is a VC fund in Beijing focused on Manufacturing and Biotechnology. Headquartered in Beijing, China Reform Fund Management Co.,Ltd (“China Reform Fund”) is a professional private equity investment firm that sponsored by China Reform Holdings Corporation Ltd(“CRHC”) together with other Central State-Owned enterprises and social institutional investors.The firm was established in August 2014 and in accord with“Regulations for the Supervision and Administration of Private Investment Funds”, and successfully registered with Asset Management Association of China. The Private Equity Fund Manager Registration Certificate was obtained in October 2014 with a serial number of P1004745.CRHC, the founder and controlling shareholder of China Reform Fund, is a stated-owned assets management corporation under direct supervision from central government. As an asset management platform, CRHC is mainly engaged in pushing forward central state-owned enterprise’s reform and restructuring process, assisting in enhancing their core competences and participating in their IPO transactions or non-public joint stock reform. It also make strategic investments in new emerging industries as well as other sectors related to national security and economic lifelines.China Reform Fund currently has one RMB fund - China Reform Investment Fund I (Limited Partnership), with a total RMB 5 billion assets under management. They have successfully completed two transactions since September 16, 2014.The investor base of their funds comprises investors from state-owned companies as well as private enterprises. With their fundraising efforts, an Umbrella Fund consists of Venture Capital Fund, Nuclear Industry Fund, M&A Fund and Fixed Income Fund is carried out smoothly.
- Total investments:
- 31
- Last investment:
- Lead investor:
- 45%
Last updated:
For AI agents: llms.txt
Industries China Reform Fund Management invests in
Stages China Reform Fund Management invests in
Countries China Reform Fund Management invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Robert Lu
|
|||
Investment Focus
Industry
- Manufacturing 10 (32%)
- Biotechnology 4 (13%)
- Semiconductor 4 (13%)
- Pharmaceutical 4 (13%)
- Advanced Materials 4 (13%)
Stage
- Series A 7 (23%)
- Series B 7 (23%)
- Series C 7 (23%)
- Private Equity 5 (16%)
- Funding Round 2 (6%)
Country
- China 27 (87%)
- United States 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Robert Lu
Executive Team Member
|
Executive Team Member | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Weihe Technology
|
Weihe Technology is a technology company focused on 5G communication technology services, Internet of Things (IoT) technology research and development, and software development. The company also provides software sales and integrated digital solutions, helping businesses enhance connectivity, improve operational efficiency, and accelerate digitaltransformation through innovative communication and intelligent technology applications. | Series A / Jul 26, 2026 | |
Aixin Semiconductor Technology
|
Aixin Semiconductor Technology specializes in the research and development, manufacturing, and sales of semiconductor front-end measurement and testing equipment. It has a production plant of more than 1,000 square meters in Shenzhen, including a thousand-level assembly and commissioning clean room, and a hundred-level, and ten-level laboratoryclean room. | Series B / Jul 20, 2026 | |
Zhongke Qingneng
|
Zhongke Qingneng is a green-tech company that specializes in the development and manufacturing of hydrogen liquefaction and cryogenic equipment. | $71.9M / Seed / Feb 01, 2026 | |
XellSmart
|
Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China. | Series C / Jan 14, 2026 | |
|
Shuoke Zhongkexin
|
Shuoke Zhongkexin is a semiconductor ion implantation company that builds comprehensive ion implanter product systems. | $99.9M / Series B / Dec 26, 2025 | |
Xingi Tech
|
Xingi Tech is a new material technology developer focusing on new material services, mainly engaged in new material technology research and development and ultra-high molecular weight polyethylene fiber production. | $141.4M / Venture - Series Unknown / Dec 04, 2025 | |
Reprogenix
|
Reprogenix is a groundbreaking medical technology firm that began with stem cell therapy for diabetes and is dedicated to expanding the use of cell therapy in a wide range of disease areas. | $70.3M / Series A / Nov 20, 2025 | |
Tailing Compressor
|
Tailing Compressoris a high-tech enterprise dedicated to providing customers with centrifugal compressors, single-stage high-speed centrifugal fans, process gas compressors, and integrated air compression system solutions. | $14M / Series A / Nov 10, 2025 | |
ZJeagles Comsemi
|
ZJeagles Comsemi is the designer and producer of optical communication chips designed for data centers and other industrial applications. | $98.2M / Series B / Oct 22, 2025 | |
|
Xingi Tech
|
Xingi Tech is a new material technology developer focusing on new material services, mainly engaged in new material technology research and development and ultra-high molecular weight polyethylene fiber production. | Series A / Sep 08, 2025 | |
| See all 31 investments → | |||
Co-Investors
Shenzhen Capital Group
4 deals together
CapitalG
3 deals together
Hillhouse Investment
3 deals together
Lake Bleu Capital
3 deals together
OrbiMed
3 deals together
HSG
3 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does China Reform Fund Management invest in?
China Reform Fund Management invests primarily in Manufacturing, Biotechnology and Semiconductor startups, most often at Series A and Series B stage. Most of the 31 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact China Reform Fund Management?
Public channels for China Reform Fund Management include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at China Reform Fund Management?
The team at China Reform Fund Management includes Robert Lu (Executive Team Member). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
